George Kemble, Ph.D.

George Kemble, Ph.D.

Chair of the BoardatSagimet Biosciences· In proxies 2022–2025

Pay in FY2023+62% from the year before

George Kemble, Ph.D. was paid $930.2K in FY2023 (Dec), up 62%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Sagimet Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sagimet BiosciencesPublic company · 4 yr
    • Chair of the Board2022 – Present · 4 yrStock in role -33%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?